420
J. Moraga et al. / Tetrahedron 67 (2011) 417e420
140(23), 124 (83), 109 (100); HREIMS calcd for C22H34O6 [MꢁH2O]þ
1.42(d, 3H, J¼7.3 Hz, C2eCH3), 1.12 (s, 3H, C4eCH3), 1.04 (s, 3H,
C8eCH3), 0.44 (d, 3H, J¼6.4 Hz, C6eCH3).
394.2355, found 394.2353.
4.4.3. 3-O-Acetylbotcineric acid (8). Compound 8 obtained from
4.7. Biotransformation of 2-benzylideneindan-1-one
fractions F9 and F10. Semi-preparative HPLC: hexaneeethyl acetate
20
95:5; flow 3 mL minꢁ1; tR¼13.2 min. Colourless oil; [
a]
ꢁ5.9ꢀ (c
Botrytis cinerea UCA 992 was grown at 25 ꢀC on a Czapeck-Dox
medium (200 mL per flask). The shaken culture was incubated in an
orbital shaker at 140 rpm under fluorescent light. 2-Benzylide-
neindan-1-one was dissolved in ethanol and then distributed over
12 flasks (150 ppm per flask) and the fermentation continued for 5
days in six flasks and 10 days in the others. The mycelium was then
filtered and the broth was extracted as described below. The sol-
vent was then evaporated and the residue was purified first on
a silica gel column and then with HPLC with an increasing gradient
of ethyl acetate to petroleum ether.
D
1.4, ethyl acetate).15
4.4.4. (þ)-Botrylactone (11). Compound 11 obtained from fractions
F5. Analytical HPLC: hexaneeethyl acetate 65:35; flow 1 mL minꢁ1
;
25
tR¼28.98 min. Colourless oil; [
a
]
D
þ19ꢀ (c 2.3, CHCl3).9,11
4.4.5. 2R, 3S, 4S, 6S, 8R, 9R-5-Hydroxy-7-(4-hydroxydec-2(3)-enoyl)
botrylactone (12). Compound 12 obtained from fractions F9 and
F10. Semi-preparative HPLC: hexaneeethyl acetate 95:5; flow
20
3 mL minꢁ1; tR¼15.1 min. Colourless oil; [
a
]
þ10.6ꢀ (c 0.9, ethyl
Chromatography of the extract fermented for 5 days produced
2-benzylideneindan-1-one (4 mg), O-methyldihydrobotrydial
(3.2 mg), botrydial (4 mg), dihydrobotrydial (3 mg), 7-deoxybo-
D
acetate); IR ymax (film) 3445, 2931, 2859, 1727, 1652, 1456,
1116 cmꢁ1; 1H NMR (400 MHz, CDCl3)
d
7.00 (dd, 1H, J¼15.6, 4.5 Hz,
H-30), 6.07 (dd, 1H, J¼15.6, 1.6 Hz, H-20), 4.93 (d, 1H, J¼10.9 Hz, H-7),
4.33 (m, 1H, H-40), 3.67 (d, 1H, J¼11.1 Hz, H-5), 3.52 (s, 1H, H-3), 2.75
(q, 1H, J¼7.4 Hz, H-2), 1.99 (m, 1H, H-6), 1.60 (m, 2H, H-50), 1.53 (s,
3H, C9eCH3), 1.46 (d, 3H, J¼7.4 Hz, C2eCH3), 1.28 (m, 8H, H-60, H-70,
H-80, H-90), 1.14 (s, 3H, C4eCH3), 1.10 (s, 3H, C8eCH3), 1.02 (d, 3H,
J¼6.4 Hz, C6eCH3), 0.87 (t, 3H, J¼6.8 Hz, H-100); 13C NMR (100 MHz,
CDCl3) 171.0 (s, C-1), 165.4 (s, C-10), 151.9 (d, C-30), 119.0 (d, C-20),
104.2 (s, C-9), 80.9 (d, C-3), 79.2 (s, C-8), 76.2 (s, C-4), 75.1 (d, C-5),
74.2 (d, C-7), 71.1 (d, C-40), 36.7 (d, C-50), 36.5 (t, C-60), 34.5 (d, C-2),
31.6 (t, C-80), 29.1 (t, C-70), 25.2 (t, C-60), 22.5 (t, C-90), 21.7 (q,
C9eCH3), 18.5 (q, C2eCH3), 18.2 (q, C4eCH3), 18.1 (q, C8eCH3), 14.0
(q, C-100), 13.8 (q, C6eCH3); EIMS m/z (rel int.) 454 [M]þ (1), 426
[MꢁCO]þ (7), 410 [MꢁCO2]þ (6); HREIMS calcd for C23 H38O7
[MꢁCO]þ 426.2618, found 426.2641.
trylactone (13,2.8 mg) and 2-(p-hydroxyphenylmethyl)indan-1-
20
one (50 mg) ([
a
]
D
þ6ꢀ (c 0.1, MeOH), 36% ee).
Chromatography of the extract fermented for 10 days produced
2-benzylideneindan-1-one (14 mg), botrydial (2 mg), dihydrobo-
trydial (3 mg), 7-deoxybotrylactone (13, 15.3 mg), botcinic acid (3,
60 mg) and 2-(p-hydroxyphenylmethyl)-7-hydroxyindan-1-one
20
(17 mg) [
a
]
ꢁ3.7ꢀ (c 0.1, MeOH, 7% ee).
D
4.7.1. 7-Deoxybotrylactone(13). Compound 13 obtained from fraction
F3. Column chromatography: hexaneeethyl acetate 80:20. Amor-
phous solid; [
a
]
25 þ2.45ꢀ (c 0.3 CHCl3); IR ymax (film) 2925, 1735, 1459,
D
1103, 950 cmꢁ1; 1H NMR (400 MHz, CDCl3)
d 3.28 (s, 1H, H-3), 2.70 (q,
1H, J¼7.3 Hz, H-2), 1.75 (m, 1H, H-6), 1.63 (m, 1H, H-5), 1.57 (m, 2H, H-
7) 1.44 (s, 3H, C9eCH3), 1.40 (d, 3H, J¼7.3 Hz, C2eCH3), 1.37 (m, 1H, H-
50),1.26 (m, 1H, H-70), 1.14 (s, 3H, C4eCH3),1.18 (s, 3H, C8eCH3), 0.95 (d,
3H, J¼6.7 Hz, C6eCH3); 13C NMR (100 MHz, CDCl3) 171.7 (s, C-1), 104.8
(s, C-9), 81.7 (d, C-3), 75.5 (s, C-8), 71.6 (s, C-4), 75.6 (d, C-5), 71.6 (d, C-
12), 41.9 (t, C-5), 39.9 (t, C-7), 34.5 (d, C-2), 26.17 (q, C4eCH3), 25.0 (q,
C8eMe), 23.4 (d, C-6), 21.6 (q, C9eCH3), 20.5 (q, C6eCH3), 18.6 (q,
C2eCH3); EIMS m/z (rel int.) 226 [MꢁCO]þ (26), 166 (36),123 (83), 109
(100); HREIMS calcd for C13H22O3 [MꢁCO]þ 226.1569, found 226.1573.
4.5. Acetylation of botrylactone
Botrylactone (11, 10 mg) was dissolved in dry pyridine (1 mL,
0.001 mmol) and acetic anhydride (2.4 mL, 24,6 mmol) was added
dropwise. The reaction mixture was stirred for 24 h. Then the solvent
wasremovedandthecrudereactionproductchromatographedtogive
botrylactone acetate (11c). Colourless oil; [
a
]
25 þ73, (c 2.4 mg, CHCl3).9
D
Acknowledgements
4.6.
a
-Methoxyphenylacetyl ester of botrylactone
This work was supported by grants from MICINN (AGL2009-
13359-C02-01) and from Junta de Andalucía (P07-FQM-02689). We
gratefully acknowledge Dr. Muriel Viaud from the UMR BIOGER,
A solution of the botrylactone (11, 10 mg, 0.037 mmol) in dry
dichloromethane CH2Cl2 (1.5 mL) was treated with DMAP (9.05 mg,
2.0 equiv) and (þ)-(2S)- or (ꢁ)-(2R)-2-methoxy-2-phenylacetic
acid MPA (13.85 mg, 2.25 equiv). After 15 min stirring at room
temperature, EDC (14.91 mg, 2.1 equiv) was added. Stirring was
maintained for 24 h. The solvent was stirred under reduced pres-
sure. Residue purification was achieved by flash column chroma-
tography on silica gel (elution with 60:40 hexane/ethyl acetate).
INRA (Versailles, France) for supplies B. cinerea mutant bcbot2D.
References and notes
1. Cutler, H. G.; Jacyno, J. M.; Harwood, J. S.; Dulik, D.; Goodrich, P. D.; Roberts, R.
G. Biosci., Biotechnol., Biochem. 1993, 57, 1980e1982.
ꢀ
ꢀ
2. Collado, I. G.; Aleu, J.; Hernandez-Galan, R.; Hanson, J. R. Phytochemistry 1996,
42, 1621e1624.
ꢀ
ꢀ
ꢀ
ꢀ
3. Reino, J. L.; Duran-Patron, R. M.; Daoubi, M.; Collado, I. G.; Hernandez-Galan, R.
-Methoxyphenylacetyl ester of botrylactone (11a). 1H
J. Org. Chem. 2006, 71, 562e565.
4.6.1. (R)-
NMR (400 MHz, CDCl3)
a
4. Tani, H.; Koshino, H.; Sakuno, E.; Nakajima, H. J. Nat. Prod. 2005, 68, 1768e1772.
5. Tani, H.; Koshino, H.; Sakuno, E.; Cutler, H. G.; Nakajima, H. J. Nat. Prod. 2006, 69,
722e725.
6. Fukui, H.; Shiina, I. Org. Lett. 2008,10, 3153e3156; Fukui, H.; Hitomi, S.; Suzuki, R.;
Ikeda, T.; Umezaki, K.; Tsuji, K.; Shiina, I. Tetrahedron Lett. 2008, 49, 6514e6517.
7. Shiina, I.; Fukui, H. Chem. Commun. 2009, 385e400.
8. Pinedo, C.; Wang, Ch.-M.; Pradier, J. M.; Dalmais, B.; Choquer, M.; Le Pecheur, P.;
Morgant, G.; Collado, I. G.; Cane, D. E.; Viaud, M. ACS Chem. Biol. 2008, 3, 791e801.
9. Welmar, K.; Tschesche, R.; Breitmaier, E. Chem. Ber. 1979, 112, 3598e3602.
10. Suga, T.; Hirata, T.; Utsumi, R.; Yoshioka, T. J. Sci. Hiroshima Univer., Ser. A 1984,
48, 75e79.
0
d
7.40 and 7.33 (m, 2H and 3H,C2 ePh), 4.87
0
0
(d, 1H, J¼10.8 Hz, H-7), 4.75(s, 1H, H-2 ), 3.39 (s, 3H, C2 eOMe), 3.27
(br s, 1H, H-3), 2.63 (q, 1H, J¼7.3 Hz, H-2), 1.90 (m, 1H, H-6), 1.71 (dd,
J¼4.7, 13.5 Hz, H-5
b
), 1.55 (dt, J¼2.7, 13.2 Hz, H-5a), 1.39(d, 3H,
J¼7.3 Hz, C2eCH3),1.26 (s, 3H, C9eCH3),1.12 (s, 3H, C8eCH3), 0.91 (d,
3H, J¼6.4 Hz, C6eCH3), 0.86 (t, 3H, J¼7.2 Hz, H-100).
4.6.2. (S)-
a
-Methoxyphenylacetyl ester of botrylactone (11b). 1H
0
11. Bruns, W.; Horns, S.; Redlich, H. Synthesis 1994, 335e342.
12. Seco, J. M.; Quinoa, E.; Riguera, R. Tetrahedron: Assymetry 2001, 12, 2915e2925.
13. Unpublished results
14. Steyn, P. S.; Vieggaar, R.; Wessels, P. L. J. Chem. Soc., PerkinTrans.11981,1298e1308.
15. Sakuno, E.; Tani, H.; Nakajima, H. Biosci., Biotechnol., Biochem. 2007, 71, 2592e2595.
NMR (400 MHz, CDCl3)
d
7.44 and 7.38 (m, 2H and 3H,C2 ePh), 4.81
~
0
0
(d, 1H, J¼10.8 Hz, H-7), 4.76(s, 1H, H-2 ), 3.40 (s, 3H, C2 eOMe), 3.27
(br s, 1H, H-3), 2.67 (q,1H, J¼7.3 Hz, H-2), 1.79 (m, 1H, H-6), 1.62 (dd,
J¼5.0, 13.5 Hz, H-5
b), 1.55 (t, J¼13.2 Hz, H-5
a), 1.52 (s, 3H, C9eCH3),